Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 5/20 | 0.64 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.64 |
| ▸ | TFEB | P19484 | 1/20 | 0.60 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.58 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | HMGCR | P04035 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | BCHE | P06276 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | CA7 | P43166 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29580852 | 1.00 | NFE2L2 (0.64) | NFE2L2TRPA1TFEBCYP1A1CYP1A2 | |
| SCHEMBL1883472 | 1.00 | NFE2L2 (0.64) | NFE2L2TRPA1TFEBCYP1A1CYP1A2 | |
| SCHEMBL1883475 | 1.00 | NFE2L2 (0.64) | NFE2L2TRPA1TFEBCYP1A1CYP1A2 | |
| SCHEMBL1603719 | 0.88 | NFE2L2 (0.79) | NFE2L2TRPA1TFEBCYP1A1CYP1A2 | |
| SCHEMBL4019329 | 0.88 | NFE2L2 (0.79) | NFE2L2TRPA1TFEBCYP1A1CYP1A2 | |
| SCHEMBL7915752 | 0.88 | NFE2L2 (0.79) | NFE2L2TRPA1TFEBCYP1A1CYP1A2 | |
| SCHEMBL3669785 | 0.84 | NFE2L2 (0.45) | NFE2L2TRPA1TFEBCYP1A1CYP1A2 | |
| SCHEMBL21110871 | 0.84 | NFE2L2 (0.45) | NFE2L2TRPA1TFEBCYP1A1CYP1A2 | |
| SCHEMBL6158840 | 0.83 | NFE2L2 (0.55) | NFE2L2TRPA1TFEBCYP1A1CYP1A2 | |
| SCHEMBL16933894 | 0.82 | NFE2L2 (0.64) | NFE2L2TRPA1TFEBCYP1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10177059-B2 | Method for manufacturing semiconductor apparatus using a base-attached encapsulant | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2019-01-08 | — | — | US | disclosed |
| US-20170330813-A1 | BASE-ATTACHED ENCAPSULANT FOR SEMICONDUCTOR ENCAPSULATION, SEMICONDUCTOR APPARATUS, AND METHOD FOR MANUFACTURING SEMICONDUCTOR APPARATUS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-11-16 | — | — | US | disclosed |
| WO-2017124087-A1 | ANTI-PARASITIC COMPOUNDS AND USES THEREOF | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2017-07-20 | — | — | WO | disclosed |
| US-8927685-B1 | Thermoset and thermoplastic compositions derived from the essential oils of herbs | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2015-01-06 | — | — | US | disclosed |
| US-20110009447-A1 | Substituted Benzoic Acid Amides and Use thereof for the Inhibition of Angiogenesis | SCHERING AG (DE) | 2011-01-13 | — | — | US | disclosed |
| EP-1280776-B1 | SUBSTITUTED BENZOIC ACID AMIDES AND USE THEREOF FOR THE INHIBITION OF ANGIOGENESIS | BAYER SCHERING PHARMA AG (DE) | 2009-10-21 | — | — | EP | disclosed |
| US-20090155388-A1 | WEIGHT PHYTO-NUTRACEUTICAL SYNERGISTIC COMPOSITION | OLALDE JOSE ANGEL | 2009-06-18 | — | — | US | disclosed |
| EP-0644888-B1 | SULPHONIUM SALTS AND PROCESS FOR PRODUCING THEM | WACKER CHEMIE GMBH (DE) | 1996-03-13 | — | — | EP | disclosed |
| EP-0618919-B1 | IODINIUM SALTS AND METHOD OF PREPARING THEM | WACKER CHEMIE GMBH (DE) | 1996-02-28 | — | — | EP | disclosed |
| US-5468890-A | Iodonium salts and process for the preparation thereof | WACKER-CHEMIE GMBH (DE) | 1995-11-21 | — | — | US | disclosed |
| US-5466845-A | Contain silane groups, photoinitiators | WACKER-CHEMIE GMBH (DE) | 1995-11-14 | — | — | US | disclosed |
| EP-0644888-A1 | SULPHONIUM SALTS AND PROCESS FOR PRODUCING THEM. | WACKER CHEMIE GMBH (DE) | 1995-03-29 | — | — | EP | disclosed |
| EP-0618919-A1 | IODINIUM SALTS AND METHOD OF PREPARING THEM. | WACKER CHEMIE GMBH (DE) | 1994-10-12 | — | — | EP | disclosed |
| WO-1993025559-A1 | SULPHONIUM SALTS AND PROCESS FOR PRODUCING THEM | WACKER-CHEMIE GMBH (DE) | 1993-12-23 | — | — | WO | disclosed |
| WO-1993013110-A1 | IODINIUM SALTS AND METHOD OF PREPARING THEM | WACKER-CHEMIE GMBH (DE) | 1993-07-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110009447-A1 | Substituted Benzoic Acid Amides and Use thereof for the Inhibition of Angiogenesis | VEGFA, EGLN2, HIF1AN | NFE2L2 324/4885TRPA1 3563/4885TFEB 36/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.